Â鶹ѧÉú¾«Æ·°æ

Zaker I. Schwabkey
( out of 22 reviews )

Zaker I. Schwabkey, MD

Languages spoken: Arabic, English

Clinical Locations

Huntsman Cancer Institute - Cancer Research North

Clinic 2D/E, BMT/Hematology
Salt Lake City
801-585-2626

  • Dr. Zaker Schwabkey is a physician and an Assistant Professor of Medicine and Clinical Investigator in the Division of Hematology & Hematologic Malignancies at the University of Utah’s Huntsman Cancer Institute. He specializes in the treatment of myeloid neoplasms, with a focus on acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), chronic myeloid leukemia (CML), and myeloproliferative neoplasms (MPN).

    Dr. Schwabkey is actively involved in clinical and translational research in his areas of expertise, and his work has been published in leading peer-reviewed journals and presented at national and international scientific conferences. He is also deeply committed to medical education and plays an integral role in training the next generation of physicians.

    He completed a postdoctoral research fellowship in genomic and cancer medicine at the University of Texas MD Anderson Cancer Center in Houston, TX. His internal medicine residency was at Albany Medical College in Albany, NY, followed by a fellowship in hematology and medical oncology at the Moffitt Cancer Center & Research Institute in Tampa, FL, where he also served as chief fellow.

    Specialties

    Board Certification

    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Hematology)
    American Board of Internal Medicine (Sub: Medical Oncology)
    National Board of Physicians and Surgeons

    Patient Rating

    4.8 /5
    ( out of 22 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    June 27, 2025
    HUNTSMAN CANCER CENTER

    He was proactive regarding my care and took steps to help me feel better.

    June 09, 2025
    HUNTSMAN CANCER CENTER

    Knowledgable, considerate,

    February 09, 2025
    HUNTSMAN CANCER CENTER

    Dr. Schwabkey came to us shook hands personally and told us about the test results in understandable words and phrases. He asked us if we had any questions and answered them to our satisfaction. After he left his nurse assistant answered more questions.In the meantime we had a couple more for the Dr. and he came back in and answered our questions. It was a very good experiance all around. Thanks

    January 06, 2025
    HUNTSMAN CANCER CENTER

    Easy talk to and explains things so I can understand

    January 05, 2025
    HUNTSMAN CANCER CENTER

    Very caring and put me at ease by taking his time to get to know me.

    December 12, 2024
    HUNTSMAN CANCER CENTER

    I think I should have been guided as to what questions I should have asked the doctor when he gave me his diagnosis. I was surprised when the doctor told me that I should just wait for my hemoglobin to drop further before he could give me treatment. [TRANSLATED]

    November 19, 2024
    HUNTSMAN CANCER CENTER

    Dr. Schwabkey was very thorough and patient, and took time to explain things in a way I could understand. He was also very thorough in answering all questions that I had.

    November 15, 2024
    HUNTSMAN CANCER CENTER

    Dr. Schwabkey was amazing.

  • Dr. Zaker Schwabkey is a physician and an Assistant Professor of Medicine and Clinical Investigator in the Division of Hematology & Hematologic Malignancies at the University of Utah’s Huntsman Cancer Institute. He specializes in the treatment of myeloid neoplasms, with a focus on acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), chronic myeloid leukemia (CML), and myeloproliferative neoplasms (MPN).

    Dr. Schwabkey is actively involved in clinical and translational research in his areas of expertise, and his work has been published in leading peer-reviewed journals and presented at national and international scientific conferences. He is also deeply committed to medical education and plays an integral role in training the next generation of physicians.

    He completed a postdoctoral research fellowship in genomic and cancer medicine at the University of Texas MD Anderson Cancer Center in Houston, TX. His internal medicine residency was at Albany Medical College in Albany, NY, followed by a fellowship in hematology and medical oncology at the Moffitt Cancer Center & Research Institute in Tampa, FL, where he also served as chief fellow.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Assistant Professor (Clinical)
    Academic Divisions Hematology & Hematologic Malignancies
    Board Certification
    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Hematology)
    American Board of Internal Medicine (Sub: Medical Oncology)
    National Board of Physicians and Surgeons

    Education history

    Fellowship Hematology/Oncology - Moffitt Cancer Center Chief Fellow
    Fellowship Hematology/Oncology - Moffitt Cancer Center Fellow
    Residency Internal Medicine - Albany Medical College Resident
    Postdoctoral Fellowship Cancer Medicine - University of Texas MD Anderson Cancer Center Postdoctoral Research Fellow
    Professional Medical Medicine - Jordan University of Science & Technology School of Medicine M.D.

    Selected Publications

    Journal Article

    1. Rami S Komrokji, MBBS, Luca Lanino, MD, Somedeb Ball, MD, Jan P Bewersdorf, MD, Monia Marchetti, MD, Giulia Maggioni, MD, Erica Travaglino, BSc, Najla H Al Ali, MSc, Pierre Fenaux, MD, Uwe Platzbecker, MD, Valeria Santini, MD, Maria Diez-Campelo, MD, Avani Singh, MD, Akriti Gupta Jain, MD, Luis E Aguirre, MD, Sarah M Tinsley-Vance, PhD, Zaker I Schwabkey, MD, Onyee Chan, MD, Zhouer Xie, MD, Andrew M Brunner, MD, Andrew T Kuykendall, MD, Prof John M Bennett, MD, Rena Buckstein, MD, Rafael Bejar, MD, Hetty E Carraway, MD, Amy E DeZern, MD, Elizabeth A Griffiths, MD, Stephanie Halene, MD, Robert P Hasserjian, MD, Jeffrey Lancet, MD, Alan F List, MD, Sanam Loghavi, MD, Olatoyosi Odenike, MD, Eric Padron, MD, Mrinal M Patnaik, MBBS, Gail J Roboz, MD, Maximilian Stahl, MD, Prof Mikkael A Sekeres, MD, David P Steensma, MD, Michael R Savona, MD, Justin Taylor, MD, Mina L Xu, MD, Kendra Sweet, MD, David A Sallman, MD, Stephen D Nimer, MD, Christopher S Hourigan, DM, Andrew H Wei, MBBS, Elisabetta Sauta, PhD, Saverio DAmico, MSc, Gianluca Curriculum Vitae Zaker I Schwabkey, MD 3 Asti, MSc, Gastone Castellani, PhD, Mattia Delleani, MSc, Alessia Campagna, MD, Uma M Borate, MD, Guillermo Sanz, MD, Fabio Efficace, PhD, Steven D Gore, MD, Tae Kon Kim, MD, Navel Daver, MD, Guillermo Garcia-Manero, MD, Maria Rozman, MD, Alberto Orfao, MD, Sa A Wang, MD, M Kathryn Foucar, MD, Ulrich Germing, MD, Torsten Haferlach, MD, Phillip Scheinberg, MD, Yasushi Miyazaki, MD, Marcelo Iastrebner, MD, Austin Kulasekararaj, MD, Thomas Cluzeau, MD, Shahram Kordasti, MD, Arjan A van de Loosdrecht, MD, Lionel Ades, MD, Amer M Zeidan, MD, Matteo G Della Porta, MD (2024). Data-driven, harmonized classification system for myelodysplastic syndromes: a consensus study from the International Consortium for Myelodysplastic Syndromes (icMDS), The Lancet Haematology, [2024]. Lancet Haematol, 11(11), e862-e872.
    2. Schwabkey ZI, Wiesnoski DH, Chang CC, Tsai WB, Pham D, Ahmed SS, Hayase T, Ortega Turrubiates MR, El-Himri RK, Sanchez CA, Hayase E, Frenk Oquendo AC, Miyama T, Halsey TM, Heckel BE, Brown AN, Jin Y, Raybaud M, Prasad R, Flores I, McDaniel L, Chapa V, Lorenzi PL, Warmoes MO, Tan L, Swennes AG, Fowler S, Conner M, McHugh K, Graf T, Jensen VB, Peterson CB, Do KA, Zhang L, Shi Y, Wang Y, Galloway-Pena JR, Okhuysen PC, Daniel-MacDougall CR, Shono Y, Burgos da Silva M, Peled JU, van den Brink MRM, Ajami N, Wargo JA, Reddy P, Valdivia RH, Davey L, Rondon G, Srour SA, Mehta RS, Alousi AM, Shpall EJ, Champlin RE, Shelburne SA, Molldrem JJ, Jamal MA, Karmouch JL, Jenq RR (2022). Diet-derived metabolites and mucus link the gut microbiome to fever after cytotoxic cancer treatment. Sci Transl Med, 14(671), eabo3445. ()
    3. Schwabkey Z, Al Ali N, Sallman D, Kuykendall A, Talati C, Sweet K, Lancet J, Padron E, Komrokji R (2021). Impact of obesity on survival of patients with myelodysplastic syndromes. Hematology, 26(1), 393-397. ()
    4. Schwabkey ZI, Al Ali N, Chan O, Sallman DA, Padron E, Kuykendall AT, Talati C, Sweet K, Lancet JE, Komrokji RS (2020). Fluorescence in Situ Hybridization (FISH) Utility for Risk Score Assessment in Patients With MDS With Normal Metaphase Karyotype. Clin Lymphoma Myeloma Leuk, 21(1), e52-e56. ()
    5. Schwabkey ZI, Sheehan FC, Bellomo C, Raval M (2020). Congenital dysfibrinogenaemia presented with preterm premature rupture of the membranes and vaginal bleeding. BMJ Case Rep, 13(9). ()

    Review

    1. Schwabkey ZI, Jenq RR (2020). Microbiome Anomalies in Allogeneic Hematopoietic Cell Transplantation. [Review]. Annu Rev Med, 71, 137-148. ()
    2. Slingerland AE, Schwabkey Z, Wiesnoski DH, Jenq RR (2017). Clinical Evidence for the Microbiome in Inflammatory Diseases. [Review]. Front Immunol, 8, 400. ()

    Book Chapter

    1. Schwabkey Z, Deutsch Y, Sallman D (2024). Aplastic Anemia. In Non-malignant hematologic disorders (1st Edition).
    2. Schwabkey Z, Abushukair H, Kareem SS, Benson K (2024). Recombinant Human Plasma Proteins in Clinical Practice. In Non-malignant hematologic disorders (1st Edition).
    3. Schwabkey Z, Pinilla J (2024). Chronic Myelogenous Leukemia. In Handbook of Hematologic Malignancies (3rd Edition).
    4. Schwabkey Z, Kuykendall A (2024). Polycythema Vera. In Handbook of Hematologic Malignancies (3rd Edition).
    5. Schwabkey Z, Kuyekndall A (2024). Essential Thrombocythemia. In Handbook of Hematologic Malignancies (3rd Edition).